Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Top Cited Papers
Open Access
- 26 December 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 17 (1), 55-63
- https://doi.org/10.1038/nm.2277
Abstract
The protein hormone adiponectin is known to have many beneficial systemic effects, including promoting cell survival, anti-inflammation and insulin sensitivity. Phil Scherer and his colleagues have found that these pleiotropic effects are mediated by a ceramidase activity associated with the two known isoforms of the adiponectin receptor. The adipocyte-derived secretory factor adiponectin promotes insulin sensitivity, decreases inflammation and promotes cell survival. No unifying mechanism has yet explained how adiponectin can exert such a variety of beneficial systemic effects. Here, we show that adiponectin potently stimulates a ceramidase activity associated with its two receptors, AdipoR1 and AdipoR2, and enhances ceramide catabolism and formation of its antiapoptotic metabolite—sphingosine-1-phosphate (S1P)—independently of AMP-dependent kinase (AMPK). Using models of inducible apoptosis in pancreatic beta cells and cardiomyocytes, we show that transgenic overproduction of adiponectin decreases caspase-8-mediated death, whereas genetic ablation of adiponectin enhances apoptosis in vivo through a sphingolipid-mediated pathway. Ceramidase activity is impaired in cells lacking both adiponectin receptor isoforms, leading to elevated ceramide levels and enhanced susceptibility to palmitate-induced cell death. Combined, our observations suggest a unifying mechanism of action for the beneficial systemic effects exerted by adiponectin, with sphingolipid metabolism as its core upstream signaling component.This publication has 62 references indexed in Scilit:
- Liver-specific Deficiency of Serine Palmitoyltransferase Subunit 2 Decreases Plasma Sphingomyelin and Increases Apolipoprotein E LevelsOnline Journal of Public Health Informatics, 2009
- Sphingosine Kinase and Sphingosine 1-Phosphate in CardioprotectionJournal of Cardiovascular Pharmacology, 2009
- PAQRs: A Counteracting Force to Ceramides?: Figure 1.Molecular Pharmacology, 2009
- Sphingolipids Function as Downstream Effectors of a Fungal PAQRMolecular Pharmacology, 2008
- Direct interaction between the inhibitor 2 and ceramideviasphingolipid‐protein binding is involved in the regulation of protein phosphatase 2A activity and signalingThe FASEB Journal, 2008
- Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphateBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2008
- “Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic TargetsPharmacological Reviews, 2008
- Probing the mechanism of FET3 repression by Izh2p overexpressionBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2007
- Disordered Lipid Metabolism and the Pathogenesis of Insulin ResistancePhysiological Reviews, 2007
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003